NCT03612596
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 55 Years to 79 Years (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be between the ages of 55 and 79 years
Exclusions: Patients with active or unstable disease
https://ClinicalTrials.gov/show/NCT03612596